144 related articles for article (PubMed ID: 3080573)
21. Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years.
Yildiz I; Ozdemir N; Celkan T; Soylu S; Karaman S; Canbolat A; Dogru O; Erginoz E; Apak H
Pediatr Hematol Oncol; 2015; 32(6):406-14. PubMed ID: 26154620
[TBL] [Abstract][Full Text] [Related]
22. Autoantibody against a 58 kD molecule in a patient with neutropenia and NK cell deficiency.
Witte T; Bode FM; Hammer M; Deicher H; Schmidt RE
Br J Haematol; 1996 Mar; 92(3):565-70. PubMed ID: 8616018
[TBL] [Abstract][Full Text] [Related]
23. [Clinical aspects of autoimmune neutropenia: relation to chronic idiopathic neutropenia].
Furusawa S; Saito K; Okuyama A; Yoshida M; Osato M; Hamaguchi H
Nihon Naika Gakkai Zasshi; 1987 Jul; 76(7):1015-21. PubMed ID: 3681076
[No Abstract] [Full Text] [Related]
24. Intravenous immunoglobulin in immune neutropenia.
Ventura A; Florean P; Pascone R; Perini R; Pocecco M; Lepore L
Helv Paediatr Acta; 1986 Mar; 41(6):495-500. PubMed ID: 3583771
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
26. [Successful high-dose intravenous gamma-globulin administration in a case of immune neutropenia].
Higuchi S; Ogata T; Takahashi H; Kuwahara Y; Nunoi H; Yanabe Y; Tsuchiya H; Chikazawa S; Akahoshi I; Matsuura T
Rinsho Ketsueki; 1987 Jan; 28(1):106-11. PubMed ID: 2437345
[No Abstract] [Full Text] [Related]
27. Intravenous gamma-globulin (Sandoglobulin) therapy in the management of four patients with immune thrombocytopenic purpura.
Blanchette VS
Vox Sang; 1985; 49 Suppl 1():32-41. PubMed ID: 2416125
[TBL] [Abstract][Full Text] [Related]
28. Acute renal failure after large doses of intravenous immune globulin.
Haskin JA; Warner DJ; Blank DU
Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
[TBL] [Abstract][Full Text] [Related]
29. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia.
Loughran TP; Kadin ME; Starkebaum G; Abkowitz JL; Clark EA; Disteche C; Lum LG; Slichter SJ
Ann Intern Med; 1985 Feb; 102(2):169-75. PubMed ID: 3966754
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G.
Issekutz AC; Derfalvi B; Käsermann F; Rowter D
Clin Immunol; 2015 Dec; 161(2):373-83. PubMed ID: 26307433
[TBL] [Abstract][Full Text] [Related]
31. Guidelines on the use of intravenous immune globulin for hematologic conditions.
Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
[TBL] [Abstract][Full Text] [Related]
32. Three generations of immunoglobulin G preparations for clinical use.
McCue JP; Hein RH; Tenold R
Rev Infect Dis; 1986; 8 Suppl 4():S374-81. PubMed ID: 3092303
[TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin-induced acute thrombocytopenia.
Gurevich-Shapiro A; Bonstein L; Spectre G; Atweh N; Gruenewal T; Shapiro M; Tadmor B; Raanani P
Transfusion; 2018 Feb; 58(2):493-497. PubMed ID: 29193103
[TBL] [Abstract][Full Text] [Related]
34. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia.
Aspalter RM; Sewell WA; Dolman K; Farrant J; Webster AD
Clin Exp Immunol; 2000 Sep; 121(3):506-14. PubMed ID: 10971518
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia.
Gonzalez EB; Guernsey BG; Ingrim NB; Ichikawa Y; Daniels JC
Arch Intern Med; 1985 May; 145(5):945-6. PubMed ID: 3922322
[TBL] [Abstract][Full Text] [Related]
36. High-dose intravenous therapy with immune globulin before delivery for idiopathic thrombocytopenic purpura.
Adderley RJ; Rogers PC; Shaw D; Wadsworth LD
Can Med Assoc J; 1984 Apr; 130(7):894-6. PubMed ID: 6423252
[TBL] [Abstract][Full Text] [Related]
37. NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia.
Ebbo M; Audonnet S; Grados A; Benarous L; Mahevas M; Godeau B; Viallard JF; Piperoglou C; Cognet C; Farnarier C; Harlé JR; Schleinitz N; Vély F
Clin Immunol; 2017 Apr; 177():18-28. PubMed ID: 26598010
[TBL] [Abstract][Full Text] [Related]
38. [Immunoglobulins--merely expensive or also useful?].
Paar WD
Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
[TBL] [Abstract][Full Text] [Related]
39. Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias.
Lusher JM; Warrier I
Am J Med; 1987 Oct; 83(4A):10-6. PubMed ID: 3118703
[TBL] [Abstract][Full Text] [Related]
40. Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity.
Jacobi C; Claus M; Wildemann B; Wingert S; Korporal M; Römisch J; Meuer S; Watzl C; Giese T
Clin Immunol; 2009 Dec; 133(3):393-401. PubMed ID: 19828380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
